Chewy’s 84.6% Autoship base and expanding healthcare ecosystem create asymmetric long-term upside after a margin-driven sell-off, despite leverage, execution and near-term demand risks.
Overview
Chewy is a pure-play online pet retailer selling consumables, hard goods, prescriptions and veterinary services directly to U.S. pet owners, with an initial capital-light expansion into Canada. Its key competitive advantage is the combination of Autoship, specialist service, fulfillment scale and an emerging healthcare ecosystem. **Autoship reached 84.6% of Q2 FY2026 net sales**, while active customers rose 3.8% to 21.705 million and normalized sales per active customer increased 3.8% to $602. Q2 revenue increased 7.3% to $3.33 billion, Adjusted EBITDA rose 23.7% to $226.7 million and margin reached 6.8%, although gross margin was flat at 30.4% and free cash flow declined 15.5% to $89.5 million. FY2026 guidance calls for $13.46-$13.57 billion of revenue and approximately $912 million of Adjusted EBITDA at the margin midpoint. At $20.91, the stock trades near 38.6x trailing P/E, but the post-earnings sell-off reflects temporary margin benefits, rising debt and cash use. Near-term catalysts include AI savings, clinic maturation, healthcare mix and pet-category stabilization. The report’s five-year base case reaches $47.86 per share, with a $50.68 probability-weighted target.